Finance

Lists
000153:SHE
Anhui Fengyuan Pharmaceutical Co., Ltd.
CNÂ¥6.42
-1.68%
(-0.11) 1D
Sep 9, 10:09:18 AM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000153...
Open
CNÂ¥6.44
High
CNÂ¥6.47
Low
CNÂ¥6.36
Mkt. cap
2.91B
Avg. vol.
20.44M
Volume
5.37M
Dividend
1.56%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
Jun 18, 2026
P/E ratio
31.60
52-wk high
CNÂ¥7.35
52-wk low
CNÂ¥4.95
EPS
CNÂ¥0.20
Shares outstanding
464.69M
No. of employees
4K
Open
CNÂ¥6.44
High
CNÂ¥6.47
Low
CNÂ¥6.36
Mkt. cap
2.91B
Avg. vol.
20.44M
Volume
5.37M
Dividend
1.56%
Quarterly dividend
CNÂ¥0.03
Ex-dividend date
Jun 18, 2026
P/E ratio
31.60
52-wk high
CNÂ¥7.35
52-wk low
CNÂ¥4.95
EPS
CNÂ¥0.20
Shares outstanding
464.69M
No. of employees
4K
About Anhui Fengyuan Pharmaceutical Co., Ltd.
CEO-
Employees4.28K
FoundedAug 30, 1997
Headquarters-
SectorPharmaceutical industry
Websitebbcayy.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.10B
733.07M
835.92M
835.44M
Cost of goods sold
948.42M
580.93M
644.51M
652.83M
Cost of revenue
948.42M
580.93M
644.51M
652.83M
Research and development expenses
12.18M
4.77M
6.42M
14.34M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
109.42M
108.52M
129.73M
123.17M
Operating expense
132.21M
124.19M
140.58M
138.55M
Total operating expenses
1.08B
705.12M
785.09M
791.38M
Operating income
17.37M
27.95M
50.84M
44.06M
Other non operating income
103.61K
-3.08M
-376.70K
-10.32M
EBT including unusual items
25.52M
11.23M
44.44M
30.26M
EBT excluding unusual items
16.56M
16.34M
45.18M
49.48M
Income tax expense
2.30M
14.64M
8.00M
-3.58M
Effective tax rate
9.03%
130.37%
18.01%
-11.84%
Other operating expenses
8.52M
421.98K
1.82M
3.64M
Net income
24.01M
-868.40K
37.01M
34.28M
Net profit margin
2.19%
-0.12%
4.43%
4.10%
Earnings per share
-
-
-
-
Interest and investment income
9.22M
365.49K
2.01M
15.74M
Interest expense
-9.85M
-9.19M
-7.29M
-
Net interest expenses
-635.10K
-8.83M
-5.28M
15.74M
Depreciation and amortization charges
-
-
-
-
EBITDA
42.47M
58.19M
81.08M
73.82M
Gain or loss from assets sale
-
326.42K
-
808.00
AI content may include mistakes. Learn more
Google apps